John
John is retired, and previously worked as a project manager in IT. John has a long-term partner. Ethnicity: white British.
John was diagnosed with MND in March 2018. Although his mother previously had the disease, he did not initially think it could be hereditary. John feels that knowing what to expect has helped him prepare for the future.
John was diagnosed with MND in March 2018, after noticing a weakness in his leg. Although his mother had died of MND, he wasn’t aware that it could be hereditary. John saw several healthcare professionals, who ruled out other causes for his symptoms. Once he was referred to a neurologist, he was quickly given a diagnosis of MND.
John felt it was important to know whether his MND was inherited, as this could influence future treatments. This was confirmed through a genetic test, and John was told he had the C9orf72 gene variant. In a way, he felt this was good new, as there is a lot of current research and trials into this particular cause.
John has 5 siblings, and his diagnosis started a debate in his family about whether to have pre-symptomatic genetic testing. Each of his siblings have taken a different approach, and John emphasises that it is important for everyone to make their own choice. One brother has recently been diagnosed with MND and frontotemporal dementia. Another brother has been tested and has discovered he carries the C9orf72 gene variant but has no symptoms yet. His final brother is currently seeking testing. John’s two sisters, who are the only siblings to have children, have both decided not to be tested currently. John feels his condition has brought the family closer, due to the need to communicate.
John has used the MND Association website, as well as information on research sites, to find out more about MND. He has used the internet to connect with other people with MND, who have been a source of practical support. John’s approach to living with MND has been to stay ahead of the gam. He feels that seeing his mother with the disease helped him know what to expect. He organised adaptations to his home early on and has been learning to use an eye gaze tablet before he needs it.
John has had to make changes to his life as his illness has progressed. He describes a process of losing activitie, as he can no longer do some of the things he did before. Although leaving the house is becoming more challenging, John plans to continue his holidays, and enjoys visits from friends and family. His partner has taken on a caregiving role, although he also has support from other carers to relieve pressure on her.
John has taken part in research around MND and has opted to donate his brain after death. He is positive about the potential of new clinical trials around inherited forms of MND, and has been invited to join a C9orf72 trial. John is planning to be assessed for eligibility, although has yet to make a decision on whether he would want to participate dueto the time commitment this would involve. He describes taking part in research as a way to contribute to finding a cure.
John emphasises that life with MND can be enjoyable and is positive about the support he has received. He feels technology has improved the lives of people with MND, particularly from when his mother was living with the disease. The availability of assistive technologies is a source of comfort for John when thinking about the future, as he knows he will be able to connect with others and what is going on in the world.